DK1274454T3 - Fremgangsmåder og sammensætninger til fremkaldelse af et immunrespons - Google Patents
Fremgangsmåder og sammensætninger til fremkaldelse af et immunresponsInfo
- Publication number
- DK1274454T3 DK1274454T3 DK01930632T DK01930632T DK1274454T3 DK 1274454 T3 DK1274454 T3 DK 1274454T3 DK 01930632 T DK01930632 T DK 01930632T DK 01930632 T DK01930632 T DK 01930632T DK 1274454 T3 DK1274454 T3 DK 1274454T3
- Authority
- DK
- Denmark
- Prior art keywords
- immune response
- variant
- chemokine
- compositions
- eliciting
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000019034 Chemokines Human genes 0.000 abstract 3
- 108010012236 Chemokines Proteins 0.000 abstract 3
- 230000003399 chemotactic effect Effects 0.000 abstract 2
- 239000002820 chemotaxin Substances 0.000 abstract 2
- 210000004443 dendritic cell Anatomy 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19883900P | 2000-04-21 | 2000-04-21 | |
| US83481401A | 2001-04-12 | 2001-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1274454T3 true DK1274454T3 (da) | 2006-05-15 |
Family
ID=26894197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01930632T DK1274454T3 (da) | 2000-04-21 | 2001-04-20 | Fremgangsmåder og sammensætninger til fremkaldelse af et immunrespons |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1274454B1 (https=) |
| JP (1) | JP4903342B2 (https=) |
| AT (1) | ATE314088T1 (https=) |
| AU (2) | AU2001257148B2 (https=) |
| CA (1) | CA2406853C (https=) |
| DE (1) | DE60116280T2 (https=) |
| DK (1) | DK1274454T3 (https=) |
| ES (1) | ES2256232T3 (https=) |
| WO (1) | WO2001080882A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7361329B2 (en) | 2000-04-21 | 2008-04-22 | Chemocentryx, Inc. | Compositions for inducing an immune response |
| WO2003035106A1 (en) * | 2001-10-24 | 2003-05-01 | Chemocentryx | Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen |
| US8012474B2 (en) | 2007-08-02 | 2011-09-06 | Nov Immune S.A. | Anti-RANTES antibodies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999029728A1 (en) * | 1997-12-11 | 1999-06-17 | University Of Maryland Biotechnology Institute | Method and composition to enhance the efficacy of a vaccine using chemokines |
| IL138075A0 (en) * | 1998-02-27 | 2001-10-31 | Univ Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
| DE69929432T2 (de) * | 1998-04-22 | 2006-09-28 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Erhöhung der immunantworten bei genetischer immunisierung durch verwendung eines chemokins |
-
2001
- 2001-04-20 ES ES01930632T patent/ES2256232T3/es not_active Expired - Lifetime
- 2001-04-20 CA CA2406853A patent/CA2406853C/en not_active Expired - Fee Related
- 2001-04-20 WO PCT/US2001/012950 patent/WO2001080882A2/en not_active Ceased
- 2001-04-20 AU AU2001257148A patent/AU2001257148B2/en not_active Ceased
- 2001-04-20 DK DK01930632T patent/DK1274454T3/da active
- 2001-04-20 JP JP2001577979A patent/JP4903342B2/ja not_active Expired - Fee Related
- 2001-04-20 EP EP01930632A patent/EP1274454B1/en not_active Expired - Lifetime
- 2001-04-20 AU AU5714801A patent/AU5714801A/xx active Pending
- 2001-04-20 DE DE60116280T patent/DE60116280T2/de not_active Expired - Lifetime
- 2001-04-20 AT AT01930632T patent/ATE314088T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1274454B1 (en) | 2005-12-28 |
| DE60116280T2 (de) | 2006-09-21 |
| JP4903342B2 (ja) | 2012-03-28 |
| AU5714801A (en) | 2001-11-07 |
| DE60116280D1 (de) | 2006-02-02 |
| EP1274454A2 (en) | 2003-01-15 |
| ATE314088T1 (de) | 2006-01-15 |
| WO2001080882A3 (en) | 2002-04-04 |
| CA2406853C (en) | 2012-06-26 |
| AU2001257148B2 (en) | 2006-03-30 |
| CA2406853A1 (en) | 2001-11-01 |
| ES2256232T3 (es) | 2006-07-16 |
| JP2003534250A (ja) | 2003-11-18 |
| WO2001080882A2 (en) | 2001-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE199096T1 (de) | Il-11 aus säugetier | |
| MXPA04000982A (es) | Metodos para movilizar celulas progenitoras/madre. | |
| IT1200176B (it) | Struttura per poltrone con sedile e schienale mobili, in particolare per uso odontoiatrico | |
| IL114444A (en) | Kit for inducing immune response against a tumor or a disease caused by an infectious agent | |
| DK1448229T3 (da) | Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr | |
| ATE496630T1 (de) | Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten | |
| FI965297A0 (fi) | Uusi LERK-5:ksi nimetty sytokiini | |
| CY1111718T1 (el) | Συνθεσεις και μεθοδοι για ανοσοθεραπεια βασιζομενη σε δενδριτικα κυτταρα | |
| ATE366800T1 (de) | Reifung von dendritischen zellen mit immunantwort modifizierenden verbindungen | |
| BRPI0212545B8 (pt) | método ex vivo ou in vitro para produzir uma população de célula dendrítica madura e método para produzir células t | |
| CY1107706T1 (el) | Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea) | |
| DE69110877D1 (de) | Idiotypen-impfung gegen b-zell-lymphoma. | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| DE69430059D1 (de) | Freisetzung und Mobilisierung hämatopoietischer Zellen | |
| WO2002088328A8 (en) | Method for generating highly active human dendritic cells from monocytes | |
| WO2001080887A3 (en) | Methods and chemokin compositions for inducing an immune response | |
| DK1274454T3 (da) | Fremgangsmåder og sammensætninger til fremkaldelse af et immunrespons | |
| SI1487482T1 (sl) | DNA cepivo proti proliferajočim endotelijskim celicam in postopki za uporabo le-tega | |
| NZ507829A (en) | Vaccine adjuvants for immunotherapy of melanoma | |
| DK1499886T3 (da) | Fremgangsmåder og sammensætninger egnet til at inducere et immunrespons | |
| DE602005005449D1 (de) | Adjuvante zusammensetzungen | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| AU3823601A (en) | Cytotoxic t lymphocytes activated by dendritic cell hybrids | |
| DE69835615D1 (de) | Induzierte zelluläre immunitität durch aktivierung der th1 und unterdrückung der th2 antwort durch macrophhagen | |
| DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung |